Vaxcyte, Inc. PCVX Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s preferred stock, par or stated value per share?
- Vaxcyte, Inc. (PCVX) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Vaxcyte, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Vaxcyte, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Vaxcyte, Inc.'s preferred stock, par or stated value per share?
- Over 2 years (2023 to 2025), Vaxcyte, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.